Facet browsing currently unavailable
Page 2 of 2477 results
Sort by: relevance publication year
Pharmacokinetics and 48-Week Efficacy of Nevirapine: 400 mg Versus 600 mg per day in HIV–Tuberculosis Coinfection Receiving Rifampicin JOURNAL ARTICLE published May 2008 in Antiviral Therapy |
A Pharmacokinetic Comparison of Adult and Paediatric Formulations of Raltegravir in Healthy Adults JOURNAL ARTICLE published August 2014 in Antiviral Therapy |
Key reports from the 9th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV 2007 JOURNAL ARTICLE published August 2007 in Antiviral Therapy |
The Ultra-Short Virological Dynamics in Response to Entecavir or Lamivudine during Chronic Hepatitis B with Spontaneous Severe Acute Exacerbation JOURNAL ARTICLE published January 2018 in Antiviral Therapy |
Immune restoration and onset of new AIDS-defining events with combination antiretroviral therapy in HIV type-1-infected immigrants in the Netherlands JOURNAL ARTICLE published August 2010 in Antiviral Therapy |
Inhibition of hepatitis B virus DNA replication by a thermostable interferon-γ variant JOURNAL ARTICLE published August 2010 in Antiviral Therapy |
Effects of HIV type-1 immune selection on susceptability to integrase inhibitor resistance JOURNAL ARTICLE published October 2009 in Antiviral Therapy |
HIV contamination of commercial PCR enzymes raises the importance of quality control of low-cost in-house genotypic HIV drug resistance tests JOURNAL ARTICLE published January 2010 in Antiviral Therapy |
Mitochondrial DNA Mutations in Ageing and Disease: Implications for HIV? JOURNAL ARTICLE published February 2015 in Antiviral Therapy |
Introduction to ‘Hepatitis B virus heterogeneity – a means to personalized care’ JOURNAL ARTICLE published April 2010 in Antiviral Therapy |
Efavirenz Intoxication Due to a NewCyp2B6Constellation JOURNAL ARTICLE published July 2013 in Antiviral Therapy |
Partial Immunological and Mitochondrial Recovery after Reducing Didanosine doses in Patients on Didanosine and Tenofovir-Based Regimens JOURNAL ARTICLE published February 2008 in Antiviral Therapy |
Effect of boosted fosamprenavir or lopinavir-based combinations on whole-body insulin sensitivity and lipids in treatment-naive HIV-type-1-positive men JOURNAL ARTICLE published November 2010 in Antiviral Therapy |
Improved Survival in HIV Treatment Programmes in Asia JOURNAL ARTICLE published August 2016 in Antiviral Therapy |
Algorithm evolution for drug resistance prediction: comparison of systems for HIV-1 genotyping JOURNAL ARTICLE published 2015 in Antiviral Therapy |
Article Commentary: Further Research Needed to Support a Policy of Antiretroviral Therapy as An HIV Prevention Initiative JOURNAL ARTICLE published April 2013 in Antiviral Therapy |
Sex-Associated Differences in Pre-Antiretroviral Therapy Plasma HIV-1 RNA in Diverse Areas of the World Vary by CD4+ T-Cell Count JOURNAL ARTICLE published October 2011 in Antiviral Therapy |
The Magnitude of Week 4 HCV RNA Decay on Pegylated Interferon/Ribavirin Accurately Predicts Virological Failure in Patients with Genotype 1 JOURNAL ARTICLE published April 2007 in Antiviral Therapy |
Liver Triglyceride Content in HIV-1-Infected Patients on Combination Antiretroviral Therapy Studied with 1H-MR Spectroscopy JOURNAL ARTICLE published February 2007 in Antiviral Therapy |
Predictive Value of Prostate Specific Antigen in a European HIV-positive Cohort: Does One Size Fit All? JOURNAL ARTICLE published August 2016 in Antiviral Therapy |